Table 1.
Patient characteristics.
Fig 1.
CONSORT diagram showing flow of participants.
Table 2.
Multilevel analysis of the impact of immunonutrition on treatment-related toxicities during CCRT.
Fig 2.
Percentage of grade 2–4 toxicities assessed by physician using CTCAE.
Fig 3.
Percentage of patient-reported outcomes using NCI-PRO-CTCAE throughout radiotherapy.
(a) Severity of mouth or throat sores (moderate, severe, and very severe); (b) Mouth or throat sores interfere with usual or daily activities (somewhat, quite a bit, and very much); (c) Severity of skin burns from radiation (moderate, severe, and very severe).